Murray, Henry W

Publications

Sort by

Co-Author Network

selected publications

The kinetoplast in the diagnosis of visceral leishmaniasis. 2022 GET IT
Times cited: 3
Fly bites and skin lesion in an asymptomatic traveler returned from Tanzania: Next steps? 2022 GET IT
Times cited: 2
Targeting IL-27 and/or IL-10 in Experimental Murine Visceral Leishmaniasis. The American journal of tropical medicine and hygiene. 2020 Academic Article GET IT
Times cited: 2
Case Report: Mucosal Leishmaniasis in New York City. 2020 GET IT
Times cited: 4
The Pretravel Consultation: Recent Updates. The American journal of medicine. 2020 Review GET IT
Chiclero's ulcer. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2020 Academic Article GET IT
Times cited: 1
Gamma Interferon-Regulated Chemokines in Leishmania donovani Infection in the Liver. Infection and immunity. 2016 Academic Article GET IT
Times cited: 15
IFN-γ-induced macrophage antileishmanial mechanisms in mice: A role for immunity-related GTPases, Irgm1 and Irgm3, in Leishmania donovani infection in the liver. Experimental parasitology. 2015 Academic Article GET IT
Times cited: 8
Cutaneous Leishmaniasis: Current Treatment Practices in the USA for Returning Travelers. Current treatment options in infectious diseases. 2015 Academic Article GET IT
Granzyme-mediated regulation of host defense in the liver in experimental Leishmania donovani infection. Infection and immunity. 2014 Academic Article GET IT
Times cited: 2
Cutaneous leishmaniasis in North Dakota. 2014 GET IT
Times cited: 19
Regulatory actions of Toll-like receptor 2 (TLR2) and TLR4 in Leishmania donovani infection in the liver. Infection and immunity. 2013 Academic Article GET IT
Times cited: 35
Leishmaniasis in the United States: treatment in 2012. The American journal of tropical medicine and hygiene. 2012 Review GET IT
Times cited: 58
Non-oral treatment with ivermectin for disseminated strongyloidiasis. 2010 GET IT
Times cited: 22
Treatment of visceral leishmaniasis in 2010: direction from Bihar State, India. Future microbiology. 2010 Editorial Article GET IT
Times cited: 14
Single-dose liposomal amphotericin B for visceral leishmaniasis in India. The New England journal of medicine. 2010 Academic Article GET IT
Times cited: 313
New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2008 Academic Article GET IT
Times cited: 166
Accelerated control of visceral Leishmania donovani infection in interleukin-6-deficient mice. Infection and immunity. 2008 Academic Article GET IT
Times cited: 37
Amphotericin B treatment for Indian visceral leishmaniasis: response to 15 daily versus alternate-day infusions. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2007 Academic Article GET IT
Times cited: 71
Responses to Leishmania donovani in mice deficient in interleukin-12 (IL-12), IL-12/IL-23, or IL-18. Infection and immunity. 2006 Academic Article GET IT
Times cited: 39
Responses to Leishmania donovani in mice deficient in both phagocyte oxidase and inducible nitric oxide synthase. The American journal of tropical medicine and hygiene. 2006 Academic Article GET IT
Times cited: 30
Visceral Leishmania donovani infection in interleukin-13-/- mice. Infection and immunity. 2006 Academic Article GET IT
Times cited: 19
Rapid, noninvasive diagnosis of visceral leishmaniasis in India: comparison of two immunochromatographic strip tests for detection of anti-K39 antibody. Journal of clinical microbiology. 2006 Academic Article GET IT
Times cited: 74
Sodium stibogluconate resistance in Leishmania donovani correlates with greater tolerance to macrophage antileishmanial responses and trivalent antimony therapy. Parasitology. 2005 Academic Article GET IT
Times cited: 24
Advances in leishmaniasis. Lancet (London, England). 2005 Review GET IT
Times cited: 1386
Antagonizing deactivating cytokines to enhance host defense and chemotherapy in experimental visceral leishmaniasis. Infection and immunity. 2005 Academic Article GET IT
Times cited: 60
Availability of miltefosine for the treatment of kala-azar in India. Bulletin of the World Health Organization. 2005 Academic Article GET IT
Times cited: 104
Prevention of relapse after chemotherapy in a chronic intracellular infection: mechanisms in experimental visceral leishmaniasis. Journal of immunology (Baltimore, Md. : 1950). 2005 Academic Article GET IT
Times cited: 42
Interleukin 10 receptor blockade--pentavalent antimony treatment in experimental visceral leishmaniasis. Acta tropica. 2005 Academic Article GET IT
Times cited: 22
Treatment of visceral leishmaniasis in 2004. The American journal of tropical medicine and hygiene. 2004 Review GET IT
Times cited: 81
A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan. The Journal of experimental medicine. 2004 Academic Article GET IT
Times cited: 184
Malaria: 30 years of experience at a New York City teaching hospital. The American journal of tropical medicine and hygiene. 2004 Academic Article GET IT
Times cited: 8
Progress in the treatment of a neglected infectious disease: visceral leishmaniasis. Expert review of anti-infective therapy. 2004 Review GET IT
Times cited: 51
Drugs against leishmaniasis: a synergy of technology and partnerships. Trends in parasitology. 2004 Review GET IT
Times cited: 73
Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2004 Academic Article GET IT
Times cited: 167
Modulation of T-cell costimulation as immunotherapy or immunochemotherapy in experimental visceral leishmaniasis. Infection and immunity. 2003 Academic Article GET IT
Times cited: 60
Immunoenhancement combined with amphotericin B as treatment for experimental visceral leishmaniasis. Antimicrobial agents and chemotherapy. 2003 Academic Article GET IT
Times cited: 55
Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasis. The Journal of infectious diseases. 2003 Academic Article GET IT
Times cited: 81
A novel defect in interferon-gamma secretion in patients with refractory nontuberculous pulmonary mycobacteriosis. Annals of internal medicine. 2003 Letter GET IT
Times cited: 26
Profound interferon gamma deficiency in patients with chronic pulmonary nontuberculous mycobacteriosis. The American journal of medicine. 2002 Academic Article GET IT
Times cited: 39
Kala-azar--progress against a neglected disease. The New England journal of medicine. 2002 Editorial Article GET IT
Times cited: 44
Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy. Infection and immunity. 2002 Academic Article GET IT
Times cited: 197
Noninvasive management of Indian visceral leishmaniasis: clinical application of diagnosis by K39 antigen strip testing at a kala-azar referral unit. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2002 Academic Article GET IT
Times cited: 56
Immunochromatographic strip-test detection of anti-K39 antibody in Indian visceral leishmaniasis. Annals of tropical medicine and parasitology. 2002 Academic Article GET IT
Times cited: 82
Tissue granuloma structure-function in experimental visceral leishmaniasis. International journal of experimental pathology. 2001 Review GET IT
Times cited: 165
Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial. BMJ (Clinical research ed.). 2001 Academic Article GET IT
Times cited: 167
Clinical and experimental advances in treatment of visceral leishmaniasis. Antimicrobial agents and chemotherapy. 2001 Review GET IT
Times cited: 198
Evaluation of HIV-1 immunogen, an immunologic modifier, administered to patients infected with HIV having 300 to 549 x 10(6)/L CD4 cell counts: A randomized controlled trial. JAMA. 2000 Academic Article GET IT
Times cited: 155
Mononuclear cell recruitment, granuloma assembly, and response to treatment in experimental visceral leishmaniasis: intracellular adhesion molecule 1-dependent and -independent regulation. Infection and immunity. 2000 Academic Article GET IT
Times cited: 37
Suppression of posttreatment recurrence of experimental visceral Leishmaniasis in T-cell-deficient mice by oral miltefosine. Antimicrobial agents and chemotherapy. 2000 Academic Article GET IT
Times cited: 38
Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment. Infection and immunity. 2000 Academic Article GET IT
Times cited: 94
Interleukin-12 regulates the response to chemotherapy in experimental visceral Leishmaniasis. The Journal of infectious diseases. 2000 Academic Article GET IT
Times cited: 97
Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2000 Academic Article GET IT
Times cited: 554
Short-course of oral miltefosine for treatment of visceral leishmaniasis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2000 Academic Article GET IT
Times cited: 134
Tropical medicine. BMJ (Clinical research ed.). 2000 Review GET IT
Times cited: 37
Visceral leishmanicidal activity of hexadecylphosphocholine (miltefosine) in mice deficient in T cells and activated macrophage microbicidal mechanisms. The Journal of infectious diseases. 2000 Academic Article GET IT
Times cited: 64
Roles of endogenous gamma interferon and macrophage microbicidal mechanisms in host response to chemotherapy in experimental visceral leishmaniasis. Infection and immunity. 2000 Academic Article GET IT
Times cited: 98
Short-course, cost-effective treatment with amphotericin B-fat emulsion cures visceral leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2000 Academic Article GET IT
Times cited: 50
Treatment of visceral leishmaniasis (kala-azar): a decade of progress and future approaches. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2000 Review GET IT
Times cited: 108
Oral treatment of visceral leishmaniasis with miltefosine. Annals of tropical medicine and parasitology. 1999 Academic Article GET IT
Times cited: 103
Kala-azar as an AIDS-related opportunistic infection. AIDS patient care and STDs. 1999 Review GET IT
Times cited: 30
Treatment of idiopathic CD4 T lymphocytopenia with IL-2. 1999 GET IT
Times cited: 55
Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani. The Journal of experimental medicine. 1999 Academic Article GET IT
Times cited: 361
Amphotericin B lipid complex in the management of antimony unresponsive Indian visceral leishmaniasis. The Journal of the Association of Physicians of India. 1999 Academic Article GET IT
Times cited: 20
Pulmonary edema in malaria. 1999 GET IT
Times cited: 1
Trial of oral miltefosine for visceral leishmaniasis. Lancet (London, England). 1998 Academic Article GET IT
Times cited: 223
Treatment of antimony-unresponsive Indian visceral leishmaniasis with ultra-short courses of amphotericin-B-lipid complex. Annals of tropical medicine and parasitology. 1998 Academic Article GET IT
Therapeutic effect of interferon-gamma gene transfer in experimental visceral leishmaniasis. The Journal of infectious diseases. 1998 Academic Article GET IT
Times cited: 11
A cluster of cases of severe cardiotoxicity among kala-azar patients treated with a high-osmolarity lot of sodium antimony gluconate. 1998 GET IT
Times cited: 99
Atovaquone alone or with fluconazole as oral therapy for Indian kala-azar. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 1998 Academic Article GET IT
Times cited: 7
Splenic cytokine responses in Indian kala-azar before and after treatment. The Journal of infectious diseases. 1998 Academic Article GET IT
Times cited: 111
Rapid accurate field diagnosis of Indian visceral leishmaniasis. Lancet (London, England). 1998 Academic Article GET IT
Times cited: 244
Costs of amphotericin B lipid complex for kala-azar. Annals of internal medicine. 1998 Letter GET IT
Times cited: 1
Response to interferon-gamma plus pentavalent antimony in Indian visceral leishmaniasis. The Journal of infectious diseases. 1997 Academic Article GET IT
Times cited: 112
Short-course, low-dose amphotericin B lipid complex therapy for visceral leishmaniasis unresponsive to antimony. Annals of internal medicine. 1997 Academic Article GET IT
Times cited: 105
Endogenous interleukin-12 regulates acquired resistance in experimental visceral leishmaniasis. The Journal of infectious diseases. 1997 Academic Article GET IT
Times cited: 88
Circulating T helper 1 (Th1) cell- and Th2 cell-associated cytokines in Indian patients with visceral leishmaniasis. The American journal of tropical medicine and hygiene. 1997 Academic Article GET IT
Times cited: 115
Kala-azar comes to New York. Archives of internal medicine. 1997 Review GET IT
Times cited: 9
Intracellular antimicrobial activity in the absence of interferon-gamma: effect of interleukin-12 in experimental visceral leishmaniasis in interferon-gamma gene-disrupted mice. The Journal of experimental medicine. 1997 Academic Article GET IT
Times cited: 147
Behavior of visceral Leishmania donovani in an experimentally induced T helper cell 2 (Th2)-associated response model. The Journal of experimental medicine. 1997 Academic Article GET IT
Times cited: 63
Delivery of human interferon-gamma via gene transfer in vitro: prolonged expression and induction of macrophage antimicrobial activity. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research. 1996 Academic Article GET IT
Times cited: 15
Current and future clinical applications of interferon-gamma in host antimicrobial defense. Intensive care medicine. 1996 Review GET IT
Times cited: 53
Interferon-gamma in infection and immunoparalysis. Intensive care medicine. 1996 Academic Article GET IT
Times cited: 5
Pentavalent antimony-mannan conjugate therapy of experimental visceral leishmaniasis. The American journal of tropical medicine and hygiene. 1996 Academic Article GET IT
Times cited: 13
Treatment of kala-azar with oral fluconazole. Lancet (London, England). 1996 Letter GET IT
Times cited: 36
Induction of macrophage antiprotozoal activity by monocyte chemotactic and activating factor. FEMS immunology and medical microbiology. 1996 Academic Article GET IT
Times cited: 19
Models of relapse of experimental visceral leishmaniasis. The Journal of infectious diseases. 1996 Academic Article GET IT
Times cited: 22
Activity of oral atovaquone alone and in combination with antimony in experimental visceral leishmaniasis. Antimicrobial agents and chemotherapy. 1996 Academic Article GET IT
Times cited: 33
Cure of antimony-unresponsive Indian visceral leishmaniasis with amphotericin B lipid complex. The Journal of infectious diseases. 1996 Academic Article GET IT
Times cited: 74
Multiple host defense defects in failure of C57BL/6 ep/ep (pale ear) mice to resolve visceral Leishmania donovani infection. Infection and immunity. 1996 Academic Article GET IT
Times cited: 7
Effect of treatment with interferon-gamma alone in visceral leishmaniasis. The Journal of infectious diseases. 1995 Academic Article GET IT
Times cited: 62
Antimicrobial response of a T cell-deficient host to cytokine therapy: effect of interferon-gamma in experimental visceral leishmaniasis in nude mice. The Journal of infectious diseases. 1995 Academic Article GET IT
Times cited: 33
Gamma interferon in the treatment of Kala-azar and other forms of Leishmaniasis. The Journal of the Association of Physicians of India. 1995 Review GET IT
Times cited: 2
Immunochemotherapy for a systemic intracellular infection: accelerated response using interferon-gamma in visceral leishmaniasis. The Journal of infectious diseases. 1995 Academic Article GET IT
Times cited: 70
Effect of granulocyte-macrophage colony-stimulating factor in experimental visceral leishmaniasis. The Journal of clinical investigation. 1995 Academic Article GET IT
Times cited: 76
Stavudine in patients with AIDS and AIDS-related complex: AIDS clinical trials group 089. The Journal of infectious diseases. 1995 Academic Article GET IT
Times cited: 57
Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis. The Journal of experimental medicine. 1995 Academic Article GET IT
Times cited: 127
Interferon-gamma and host antimicrobial defense: current and future clinical applications. The American journal of medicine. 1994 Review GET IT
Times cited: 110
Successful treatment of refractory visceral leishmaniasis in India using antimony plus interferon-gamma. The Journal of infectious diseases. 1994 Academic Article GET IT
Times cited: 85
Onchocerciasis in New York City. The Moa-Manhattan connection. 1994 GET IT
Times cited: 22
Colorado tick fever in a resident of New York City. 1994 GET IT
Times cited: 6
Role and effect of TNF-alpha in experimental visceral leishmaniasis. Journal of immunology (Baltimore, Md. : 1950). 1994 Academic Article GET IT
Times cited: 121
Blood monocytes: differing effector role in experimental visceral versus cutaneous leishmaniasis. Parasitology today (Personal ed.). 1994 Academic Article GET IT
Times cited: 24
Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis. Infection and immunity. 1994 Academic Article GET IT
Times cited: 170
Circulating Borrelia burgdorferi in patients with acute Lyme disease: results of blood cultures and serum DNA analysis. The Journal of infectious diseases. 1993 Academic Article GET IT
Times cited: 32
Cytokines as antimicrobial therapy for the T cell-deficient patient: prospects for treatment of nonviral opportunistic infections. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 1993 Review GET IT
Times cited: 13
Role and effect of IL-2 in experimental visceral leishmaniasis. Journal of immunology (Baltimore, Md. : 1950). 1993 Academic Article GET IT
Times cited: 100
Treatment of experimental visceral leishmaniasis in a T-cell-deficient host: response to amphotericin B and pentamidine. Antimicrobial agents and chemotherapy. 1993 Academic Article GET IT
Times cited: 46
Immunochemotherapy for visceral leishmaniasis: a controlled pilot trial of antimony versus antimony plus interferon-gamma. The American journal of tropical medicine and hygiene. 1993 Academic Article GET IT
Times cited: 74
Response to treatment for an intracellular infection in a T cell-deficient host: toxoplasmosis in nude mice. The Journal of infectious diseases. 1993 Academic Article GET IT
Times cited: 9
Effector role of blood monocytes in experimental visceral leishmaniasis. Infection and immunity. 1993 Academic Article GET IT
Times cited: 39
Lymphocyte proliferation assay in Lyme disease. The Journal of infectious diseases. 1992 Letter GET IT
Times cited: 3
The interferons, macrophage activation, and host defense against nonviral pathogens. Journal of interferon research. 1992 Review GET IT
Times cited: 17
Interferon-gamma treatment for Mycobacterium avium-intracellular complex bacillemia in patients with AIDS. The Journal of infectious diseases. 1992 Letter GET IT
Times cited: 48
Malaria--the mime revisited: fifteen more years of experience at a New York City teaching hospital. The American journal of medicine. 1992 Academic Article GET IT
Times cited: 76
Not everything that glitters is Lyme disease. 1992 GET IT
Times cited: 2
Interleukin-2 treatment, interferon-gamma induction, and AIDS monocyte activation. The American journal of medicine. 1992 Letter GET IT
Times cited: 9
Acquired resistance and granuloma formation in experimental visceral leishmaniasis. Differential T cell and lymphokine roles in initial versus established immunity. Journal of immunology (Baltimore, Md. : 1950). 1992 Academic Article GET IT
Times cited: 111
L-arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes. The Journal of infectious diseases. 1992 Academic Article GET IT
Times cited: 148
Drug fever induced by heparin. The American journal of medicine. 1992 Letter GET IT
Times cited: 10
Gamma interferon-activated human macrophages and Toxoplasma gondii, Chlamydia psittaci, and Leishmania donovani: antimicrobial role of limiting intracellular iron. Infection and immunity. 1991 Academic Article GET IT
Times cited: 42
Human immunodeficiency virus infection and bacteremic meningococcal pneumonia. The Journal of infectious diseases. 1991 Letter GET IT
Times cited: 10
Response to chemotherapy in experimental visceral leishmaniasis: T cell-dependent but interferon-gamma- and interleukin-2-independent. The Journal of infectious diseases. 1991 Academic Article GET IT
Times cited: 17
Use of granulocyte-macrophage colony stimulating factor for treatment of drug-induced agranulocytosis. Reviews of infectious diseases. 1991 Letter GET IT
Times cited: 12
Defect in the tissue cellular immune response: experimental visceral leishmaniasis in euthymic C57BL/6 ep/ep mice. Infection and immunity. 1990 Academic Article GET IT
Times cited: 14
Septic pulmonary embolism complicating a central venous catheter. 1990 GET IT
Times cited: 6
Suppression of T-lymphocyte responses to Entamoeba histolytica antigen by immune sera. Infection and immunity. 1990 Academic Article GET IT
Times cited: 24
Secondary peritonitis and intra-abdominal abscess. Hospital practice (Office ed.). 1990 Review GET IT
Effect of continuous administration of interferon-gamma in experimental visceral leishmaniasis. The Journal of infectious diseases. 1990 Academic Article GET IT
Times cited: 65
Isolated meningitis caused by Blastoschizomyces capitatus. The Journal of infectious diseases. 1990 Letter GET IT
Times cited: 23
Fungal cholecystitis and AIDS. The Journal of infectious diseases. 1990 Letter GET IT
Times cited: 10
Gamma interferon, cytokine-induced macrophage activation, and antimicrobial host defense. In vitro, in animal models, and in humans. Diagnostic microbiology and infectious disease. 1990 Review GET IT
Times cited: 66
Interferon-gamma therapy in AIDS for mononuclear phagocyte activation. Biotherapy (Dordrecht, Netherlands). 1990 Review GET IT
Times cited: 7
Experimental visceral leishmaniasis: role of endogenous IFN-gamma in host defense and tissue granulomatous response. Journal of immunology (Baltimore, Md. : 1950). 1989 Academic Article GET IT
Times cited: 154
IFN-gamma and IFN-alpha induce the expression and synthesis of Leu 13 antigen by cultured human endothelial cells. Journal of immunology (Baltimore, Md. : 1950). 1989 Academic Article GET IT
Times cited: 33
Antigen-stimulated human interferon-gamma generation: role of accessory cells and their expressed or secreted products. Clinical and experimental immunology. 1989 Academic Article GET IT
Times cited: 9
Progression to AIDS in patients with lymphadenopathy or AIDS-related complex: reappraisal of risk and predictive factors. The American journal of medicine. 1989 Academic Article GET IT
Times cited: 34
Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis. The Journal of clinical investigation. 1989 Academic Article GET IT
Times cited: 103
Interferon-gamma and Mycobacterium avium-intracellulare infection. The Journal of infectious diseases. 1989 Academic Article GET IT
Times cited: 51
Role of tryptophan degradation in respiratory burst-independent antimicrobial activity of gamma interferon-stimulated human macrophages. Infection and immunity. 1989 Academic Article GET IT
Times cited: 161
Monocytes in HIV infection. Reviews of infectious diseases. 1989 Letter GET IT
In vivo killing of intracellular visceral Leishmania donovani by a macrophage-targeted hydrogen peroxide-generating system. The Journal of infectious diseases. 1988 Academic Article GET IT
Times cited: 10
Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients. The American journal of medicine. 1988 Academic Article GET IT
Times cited: 120
T4+ cell production of interferon gamma and the clinical spectrum of patients at risk for and with acquired immunodeficiency syndrome. Archives of internal medicine. 1988 Academic Article GET IT
Times cited: 30
Circulating interferon gamma in AIDS patients treated with interleukin-2. The New England journal of medicine. 1988 Letter GET IT
Times cited: 16
Role of L3T4+ and LyT-2+ cells in experimental visceral leishmaniasis. Journal of immunology (Baltimore, Md. : 1950). 1988 Academic Article GET IT
Times cited: 136
The dynamics of granuloma formation in experimental visceral leishmaniasis. The Journal of experimental medicine. 1988 Academic Article GET IT
Times cited: 118
Immunochemotherapy for intracellular Leishmania donovani infection: gamma interferon plus pentavalent antimony. The Journal of infectious diseases. 1988 Academic Article GET IT
Times cited: 128
T lymphocyte responses to mycobacterial antigen in AIDS patients with disseminated Mycobacterium avium-Mycobacterium intracellulare infection. Chest. 1988 Academic Article GET IT
Times cited: 13
Interferon-gamma, the activated macrophage, and host defense against microbial challenge. Annals of internal medicine. 1988 Review GET IT
Times cited: 335
Survival of intracellular pathogens within human mononuclear phagocytes. Seminars in hematology. 1988 Review GET IT
Times cited: 22
Agonist and antagonist effects of interferon alpha and beta on activation of human macrophages. Two classes of interferon gamma receptors and blockade of the high-affinity sites by interferon alpha or beta. The Journal of experimental medicine. 1988 Academic Article GET IT
Times cited: 62
Macrophage activation in the acquired immunodeficiency syndrome. Advances in experimental medicine and biology. 1988 Review GET IT
Times cited: 6
Coping with AIDS. The special problems of New York City. The New England journal of medicine. 1987 Academic Article GET IT
Times cited: 44
Accessory cell function of AIDS monocytes. The Journal of infectious diseases. 1987 Letter GET IT
Times cited: 14
Antigen-induced human interferon-gamma production. Differential dependence on interleukin 2 and its receptor. Journal of immunology (Baltimore, Md. : 1950). 1987 Academic Article GET IT
Times cited: 37
Ribavirin pharmacodynamics in high-risk patients for acquired immunodeficiency syndrome. Clinical pharmacology and therapeutics. 1987 Academic Article GET IT
Times cited: 36
In vitro granuloma formation in experimental visceral leishmaniasis. The Journal of infectious diseases. 1987 Letter GET IT
Times cited: 1
The role of gamma interferon in the generation of human macrophages cytotoxic for Entamoeba histolytica trophozoites. The American journal of tropical medicine and hygiene. 1987 Academic Article GET IT
Times cited: 35
In vitro and in vivo activation of human mononuclear phagocytes by interferon-gamma. Studies with normal and AIDS monocytes. Journal of immunology (Baltimore, Md. : 1950). 1987 Academic Article GET IT
Times cited: 109
Experimental visceral leishmaniasis: production of interleukin 2 and interferon-gamma, tissue immune reaction, and response to treatment with interleukin 2 and interferon-gamma. Journal of immunology (Baltimore, Md. : 1950). 1987 Academic Article GET IT
Times cited: 156
The local cellular immune response in experimental leishmaniasis. Annales de l'Institut Pasteur. Immunology. 1987 Academic Article GET IT
Times cited: 5
Presence of a macrophage-mediated suppressor cell mechanism during cell-mediated immune response in experimental visceral leishmaniasis. Infection and immunity. 1986 Academic Article GET IT
Times cited: 22
Oxygen-independent inhibition of intracellular Chlamydia psittaci growth by human monocytes and interferon-gamma-activated macrophages. Journal of immunology (Baltimore, Md. : 1950). 1986 Academic Article GET IT
Times cited: 34
Why is Listeria monocytogenes not a pathogen in the acquired immunodeficiency syndrome?. Archives of internal medicine. 1986 Academic Article GET IT
Times cited: 42
Patients treated for amebic liver abscess develop cell-mediated immune responses effective in vitro against Entamoeba histolytica. Journal of immunology (Baltimore, Md. : 1950). 1986 Academic Article GET IT
Times cited: 72
Cellular resistance to protozoal infection. Annual review of medicine. 1986 Academic Article GET IT
Times cited: 24
Immunologic developments in AIDS--1985. The Year in immunology. 1986 Review GET IT
Times cited: 1
Patients at risk for AIDS-related opportunistic infections. Clinical manifestations and impaired gamma interferon production. The New England journal of medicine. 1985 Academic Article GET IT
Times cited: 142
Production of and in vitro response to interleukin 2 in the acquired immunodeficiency syndrome. The Journal of clinical investigation. 1985 Academic Article GET IT
Times cited: 62
Activation of tissue macrophages from AIDS patients: in vitro response of AIDS alveolar macrophages to lymphokines and interferon-gamma. Journal of immunology (Baltimore, Md. : 1950). 1985 Academic Article GET IT
Times cited: 82
Liver macrophages in murine listeriosis. Cell-mediated immunity is correlated with an influx of macrophages capable of generating reactive oxygen intermediates. The Journal of experimental medicine. 1985 Academic Article GET IT
Times cited: 81
Murine Kupffer cells. Mononuclear phagocytes deficient in the generation of reactive oxygen intermediates. The Journal of experimental medicine. 1985 Academic Article GET IT
Times cited: 112
Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma. Journal of immunology (Baltimore, Md. : 1950). 1985 Academic Article GET IT
Times cited: 257
Human mononuclear phagocyte antiprotozoal mechanisms: oxygen-dependent vs oxygen-independent activity against intracellular Toxoplasma gondii. Journal of immunology (Baltimore, Md. : 1950). 1985 Academic Article GET IT
Times cited: 124
Salmonella infections in patients with the acquired immunodeficiency syndrome. 1985 GET IT
Times cited: 172
Immunologic developments in AIDS--1984. The Year in immunology. 1985 Academic Article GET IT
Reversible defect in antigen-induced lymphokine and gamma-interferon generation in cutaneous leishmaniasis. 1984 GET IT
Times cited: 16
Activation of human macrophages. Comparison of other cytokines with interferon-gamma. The Journal of experimental medicine. 1984 Academic Article GET IT
Times cited: 291
Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Annals of internal medicine. 1984 Academic Article GET IT
Times cited: 649
Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome. The New England journal of medicine. 1984 Academic Article GET IT
Times cited: 407
Cellular immunity and the acquired immune deficiency syndrome: failure to secrete lymphokines and gamma interferon. Survey and synthesis of pathology research. 1984 Review GET IT
Times cited: 3
Macrophage activation: enhanced oxidative and antiprotozoal activity. Contemporary topics in immunobiology. 1984 Review GET IT
Times cited: 15
Opportunistic infections and impaired cell-mediated immune responses in patients with the acquired immune deficiency syndrome. Transactions of the American Clinical and Climatological Association. 1984 Academic Article GET IT
Times cited: 4
Gamma-interferon is the factor in lymphokine that activates human macrophages to inhibit intracellular Chlamydia psittaci replication. Journal of immunology (Baltimore, Md. : 1950). 1983 Academic Article GET IT
Times cited: 85
Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine. The Journal of clinical investigation. 1983 Academic Article GET IT
Times cited: 289
Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. The Journal of experimental medicine. 1983 Academic Article GET IT
Times cited: 1408
Vancomycin serum levels and toxicity in chronic hemodialysis patients with Staphylococcus aureus bacteremia. Clinical nephrology. 1983 Academic Article GET IT
Times cited: 29
Killing of intracellular Leishmania donovani by human mononuclear phagocytes. Evidence for oxygen-dependent and -independent leishmanicidal activity. The Journal of clinical investigation. 1983 Academic Article GET IT
Times cited: 113
Lymphokine enhances oxygen-independent activity against intracellular pathogens. The Journal of experimental medicine. 1983 Academic Article GET IT
Times cited: 36
Suppression of macrophage antimicrobial activity by a tumor cell product. Journal of immunology (Baltimore, Md. : 1950). 1983 Academic Article GET IT
Times cited: 21
How protozoa evade intracellular killing. Annals of internal medicine. 1983 Academic Article GET IT
Times cited: 4
Lymphokine stimulated macrophages inhibit intracellular Chlamydia psittaci replication by mechanisms distinct from intracellular inhibition of Toxoplasma gondii replication. Advances in experimental medicine and biology. 1983 Academic Article GET IT
Times cited: 2
Macrophage oxygen-dependent killing of intracellular parasites: Toxoplasma and Leishmania. Advances in experimental medicine and biology. 1983 Academic Article GET IT
Times cited: 9
Cell-mediated immune response in experimental visceral leishmaniasis. I. Correlation between resistance to Leishmania donovani and lymphokine-generating capacity. Journal of immunology (Baltimore, Md. : 1950). 1982 Academic Article GET IT
Times cited: 87
Cell-mediated immune response in experimental visceral leishmaniasis. II. Oxygen-dependent killing of intracellular Leishmania donovani amastigotes. Journal of immunology (Baltimore, Md. : 1950). 1982 Academic Article GET IT
Times cited: 118
Pretreatment with phorbol myristate acetate inhibits macrophage activity against intracellular protozoa. Journal of the Reticuloendothelial Society. 1982 Academic Article GET IT
Times cited: 36
Regulation of arachidonic acid metabolism by macrophage activation. The Journal of experimental medicine. 1982 Academic Article GET IT
Times cited: 124
Quinacrine-induced psychiatric disturbances. 1982 GET IT
Times cited: 11
Effect of hydrocortisone on macrophage response to lymphokine. Infection and immunity. 1982 Academic Article GET IT
Times cited: 25
An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. The New England journal of medicine. 1981 Academic Article GET IT
Times cited: 961
Susceptibility of Entamoeba histolytica to oxygen intermediates. Molecular and biochemical parasitology. 1981 Academic Article GET IT
Times cited: 39
Interaction of Leishmania with a macrophage cell line. Correlation between intracellular killing and the generation of oxygen intermediates. The Journal of experimental medicine. 1981 Academic Article GET IT
Times cited: 48
Susceptibility of Leishmania to oxygen intermediates and killing by normal macrophages. The Journal of experimental medicine. 1981 Academic Article GET IT
Times cited: 185
Is the appendix boring?. Archives of internal medicine. 1981 Editorial Article GET IT
Times cited: 4
Tumor cell anti-oxidant defenses. Inhibition of the glutathione redox cycle enhances macrophage-mediated cytolysis. The Journal of experimental medicine. 1981 Academic Article GET IT
Times cited: 175
Ventriculoatrial shunting for hydrocephalus complicating tuberculous meningitis. 1981 GET IT
Times cited: 23
Macrophage oxygen-dependent antimicrobial activity. III. Enhanced oxidative metabolism as an expression of macrophage activation. The Journal of experimental medicine. 1980 Academic Article GET IT
Times cited: 130
Macrophage oxygen-dependent antimicrobial activity. IV. Role of endogenous scavengers of oxygen intermediates. The Journal of experimental medicine. 1980 Academic Article GET IT
Times cited: 47
Tuberculous meningitis in a puerperal woman. 1980 GET IT
Times cited: 10
The macrophage as an effector cell. The New England journal of medicine. 1980 Academic Article GET IT
Times cited: 417
Appendicitis with perforation: a reminder to internists. 1980 GET IT
Times cited: 3
Atypical pneumonias. The Medical clinics of North America. 1980 Review GET IT
Times cited: 34
Mononuclear phagocyte antimicrobial and antitumor activity: the role of oxygen intermediates. The Journal of investigative dermatology. 1980 Academic Article GET IT
Times cited: 21
Mycoplasma pneumoniae infection. Archives of internal medicine. 1980 Letter GET IT
Times cited: 2
Fever of undetermined origin. Archives of internal medicine. 1979 Editorial Article GET IT
Macrophage oxygen-dependent antimicrobial activity. I. Susceptibility of Toxoplasma gondii to oxygen intermediates. The Journal of experimental medicine. 1979 Academic Article GET IT
Times cited: 120
Macrophage oxygen-dependent antimicrobial activity. II. The role of oxygen intermediates. The Journal of experimental medicine. 1979 Academic Article GET IT
Times cited: 137
Fever and pulmonary thromboembolism. The American journal of medicine. 1979 Academic Article GET IT
Times cited: 51
Factitious fever updated. Archives of internal medicine. 1979 Academic Article GET IT
Times cited: 7
Prophylaxis against ampicillin-associated diarrhea with a lactobacillus preparation. American journal of hospital pharmacy. 1979 Academic Article GET IT
Times cited: 151
Fatal retroperitoneal hemorrhage. An unusual complication of renal cortical abscess. 1979 GET IT
Times cited: 9
Serious infections from Bacillus sp. 1979 GET IT
Times cited: 138
Colovesical fistula. JAMA. 1979 Letter GET IT
Antimicrobial therapy in pulmonary aspiration. The American journal of medicine. 1979 Academic Article GET IT
Times cited: 21
Uveitis and the immunologically compromised host. The New England journal of medicine. 1978 Letter GET IT
Bacterial invasion of pulmonary vessels. Pseudomonas bacteremia mimicking pulmonary thromboembolism with infarction. 1978 GET IT
Times cited: 23
Staphylococcus aureus carriage rate of patients receiving long-term hemodialysis. Archives of internal medicine. 1978 Academic Article GET IT
Times cited: 124
Septic bursitis. Annals of internal medicine. 1978 Letter GET IT
Times cited: 2
Nafcillin therapy for Staphylococcus aureus endocarditis. Antimicrobial agents and chemotherapy. 1978 Academic Article GET IT
Times cited: 10
Transient autoimmune hemolytic anemia and pulmonary tuberculosis. The New England journal of medicine. 1978 Letter GET IT
Times cited: 21
Streptococcus bovis bacteremia and underlying gastrointestinal disease. Archives of internal medicine. 1978 Academic Article GET IT
Times cited: 112
Serious infections caused by Streptococcus milleri. 1978 GET IT
Times cited: 107
Fever, rash, and muscle tenderness. A distinctive clinical presentation of disseminated candidiasis. 1978 GET IT
Times cited: 93
Retinitis: a manifestation of primary or secondary cytomegalovirus infection?. Archives of internal medicine. 1978 Letter GET IT
The adult respiratory distress syndrome associated with miliary tuberculosis. 1978 GET IT
Times cited: 63
Aspergillosis. JAMA. 1977 Letter GET IT
Times cited: 10
Cytomegalovirus retinitis in adults. A manifestation of disseminated viral infection. 1977 GET IT
Times cited: 99
Unusual pleocytosis in aseptic meningitis. The New England journal of medicine. 1977 Letter GET IT
Liver biopsy septicemia. Gastroenterology. 1977 Letter GET IT
Times cited: 5
Pulmonary mucormycosis: one hundred years later. Chest. 1977 Academic Article GET IT
Times cited: 20
Staphylococcal septicemia and disseminated intravascular coagulation. Staphylococcus aureus endocarditis mimicking meningococcemia. 1977 GET IT
Times cited: 31
Spontaneous bacterial empyema, pericarditis, and peritonitis in cirrhosis. Gastroenterology. 1977 Letter GET IT
Times cited: 6
Urinary temperature: a clue to early diagnosis of factitious fever. The New England journal of medicine. 1977 Academic Article GET IT
Times cited: 13
Perinephric abscess: an unusual presentation of perforation of the colon. 1977 GET IT
Times cited: 18
Fever with dissecting aneurysm of the aorta. 1976 GET IT
Times cited: 33
Arizona hinshawii osteomyelitis with antecedent enteric fever and sepsis. A case report with a review of the literature. 1976 GET IT
Times cited: 11
Candida arthritis. A manifestation of disseminated candidiasis. 1976 GET IT
Times cited: 49
Combination antibiotic therapy in staphylococcal endocarditis. The use of methicillin sodium-gentamicin sulfate therapy. 1976 GET IT
Times cited: 30
Unusual manifestation of tuberculosis: TE fistula. The American journal of medicine. 1976 Review GET IT
Times cited: 38
Disseminated aspergillosis in a renal transplant patient: Diagnostic difficulties re-emphasized. 1975 GET IT
Times cited: 25
Letter: "Goalpost fever". Annals of internal medicine. 1975 Academic Article GET IT
Pulmonary mucormycosis with massive fatal hemoptysis. Chest. 1975 Academic Article GET IT
Times cited: 39
The protean manifestations of Mycoplasma pneumoniae infection in adults. The American journal of medicine. 1975 Review GET IT
Times cited: 209
Letter: Cardiac Munchausen syndrome. Annals of internal medicine. 1974 Academic Article GET IT
Times cited: 2
Letter: Allergic reactions to amphotericin B. The New England journal of medicine. 1974 Academic Article GET IT
Times cited: 12
Disseminated paracoccidioidomycosis (South American blastomycosis) in the United States. The American journal of medicine. 1974 Review GET IT
Times cited: 36
Exercise to prevent coronary heart disease. An experimental study of the effects of training on risk factors for coronary disease in men. The American journal of medicine. 1969 Academic Article GET IT
Times cited: 121

more ...

less ...

Background

education and training

M.D., Cornell University Medical College 1972
B.A., Cornell University 1968

Contact

full name

Henry W Murray

primary email

hwmurray@med.cornell.edu

webpage

Clinical Profile

VIVO Weill Cornell Medical College

Henry W Murray Professor of Medicine

Publications

selected publications

Background

education and training

Contact

full name

primary email

webpage

Phone

Publications

selected publications

Background

education and training

Contact

full name

primary email

webpage